首页> 外文期刊>Clinical and experimental hypertension: CEH >Beneficial effect of combination therapy comprising angiotensin II receptor blocker plus calcium channel blocker on plasma adiponectin levels.
【24h】

Beneficial effect of combination therapy comprising angiotensin II receptor blocker plus calcium channel blocker on plasma adiponectin levels.

机译:包含血管紧张素II受体阻滞剂和钙通道阻滞剂的联合疗法对血浆脂联素水平的有益作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The study aim was to examine the effect of combination therapy comprising angiotensin receptor blocker plus calcium antagonist on post-treatment plasma adiponectin levels compared to pretreatment levels. There was a significant gender difference in the relationship between preadiponectin level and age. In the search for contributing factors for treatment-based changes in adiponectin levels, these effects of gender and age were considered in statistical analysis. The adiponectin level in the combination therapy group was further increased compared to that in each of the monotherapy groups, despite there being no significant difference in antihypertensive effect, indicating that the combined medication provided an effect beyond that of lowering blood pressure.
机译:研究目的是检查与血管紧张素受体阻滞剂加钙拮抗剂联合治疗与治疗前血浆脂联素水平相比的效果。脂联素水平与年龄之间的关系存在明显的性别差异。在寻找基于治疗的脂联素水平变化的影响因素时,在统计分析中考虑了性别和年龄的这些影响。尽管降压作用没有显着差异,但与每个单药治疗组相比,联合治疗组的脂联素水平进一步提高,这表明联合用药所提供的作用超出了降低血压的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号